What is Kawasaki Disease (mucocutaneous lymph node syndrome)?

THERAPEUTIC MANAGEMENT

The administration of acetylsalicylic acid (aspirin) or ibuprofen decreases inflammation and blocks platelet aggreagation. Abciximab is a platelet receptor inhibitor specific for Kawasaki disease. IV immune globulin can also be administered to reduce the immune response. Steroids, which may increase aneurysm formation, are contraindicated. If the child is left with coronary artery disease from stenosis of the coroary arteries, coronary artery bypass surgery may be necessary in the future.


Privacy Policy

Copyright © 2007 Nursing-Nurse.Com. All rights reserved.